What's new

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 37, Status: Authorised

Feb 27, 2025 - 10:28
 0
Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 37, Status: Authorised
Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 37, Status: Authorised
Read More

Tags:

Previous Article

EU Green Deal: A Growth Strategy for New Economic and Business Models

Next Article

Human medicines European public assessment report (EPAR): Spinraza, nusinersen, ...

Related Posts

Certificates Processing System: Demo & Q&A session for industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 March 2025, 12:30 (CET) to 13 March 2025, 13:00 (CET)

Certificates Processing System: Demo & Q&A session for ...

Feb 26, 2025  0

European Medicines Agency's data protection notice on t...

Mar 12, 2025  0

Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 8, 2025  0